StockData
Aurinia Pharmaceuticals Inc. logo

Aurinia Pharmaceuticals Inc. (AUPH) stock

AUPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 13/3058% below fair value
$15.13−0.27 (-1.75%)

Close on Nov 18, 2026Market cap $2.03BP/E 6.6Yield –

Aurinia Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

No total debt figures for Aurinia Pharmaceuticals

Aurinia Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Aurinia Pharmaceuticals figures

See a number that looks wrong?